Efficacy of milnacipran on cognitive dysfunction with post-stroke depression: Preliminary open-label study

Psychiatry and Clinical Neurosciences

Volumn 60, Issue 5, 2006, Pages 584-589

  Sato, Shinji ^a,b   Yamakawa, Yuriko ^b,c   Terashima, Yasushi ^b   Ohta, Hitoshi ^c   Asada, Takashi ^b  

^a Tsukuba Memorial Hospital   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c IBARAKI PREFECTURAL UNIVERSITY OF HEALTH SCIENCES   (Japan)

Author keywords

Cognitive impairment; Depression of dementia; Milnacipran; Post stroke depression; Serotonin norepinephrine reuptake inhibitor

Indexed keywords

MILNACIPRAN; SEROTONIN UPTAKE INHIBITOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DRUG EFFICACY; FEMALE; HAMILTON SCALE; HUMAN; MALE; MINI MENTAL STATE EXAMINATION; POST STROKE DEPRESSION; STROKE; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADULT; AGED; AGED, 80 AND OVER; ANTIDEPRESSIVE AGENTS; CEREBROVASCULAR ACCIDENT; COGNITION DISORDERS; CYCLOPROPANES; DEPRESSIVE DISORDER; DEPRESSIVE DISORDER, MAJOR; FEMALE; FUNCTIONAL LATERALITY; HUMANS; MALE; MIDDLE AGED; MOOD DISORDERS; PSYCHIATRIC STATUS RATING SCALES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33748352336     PISSN: 13231316     EISSN: 14401819     Source Type: Journal    
DOI: 10.1111/j.1440-1819.2006.01562.x     Document Type: Article

References (29)

1. Ministry of Health, Labor and Welfare. Annual Report on Health and Welfare. Ministry of Health, Labor and Welfare, Japan, 2004.
2. Robinson RG. Poststroke depression: prevalence, diagnosis, treatment and disease progression. Biol. Psychiatry 2003; 54: 376-387.
3. Astrom M, Adolfsson R, Asplund K. Major depression in stroke patients: a 3-year longitudinal study. Stroke 1993; 24: 976-1282.
4. Eastwood MR, Rifat SL, Nobbs H, Ruderman J. Mood disorder following cerebrovascular accident. Br. J. Psychiatry 1989; 154: 195-200.
5. Lipsey JR, Robinson RG, Pearlson GD, Rao K, Price TR. Mood change following bilateral hemisphere brain injury. Br. J. Psychiatry 1983; 143: 266-273.
6. Herrmann N, Black SE, Lawrence J, Szekely C, Szalai JP. The sunnybrook Stroke Study. A prospective study of depressive symptoms and functional outcome. Stroke 1998; 29: 618-624.
7. Diamond PT, Holroyd S, Macciocchi SN, Felsenthal G. Prevarence of depression and outcome on the geriatric rehabilitation unit. Am. J. Phys. Med. Rehabil. 1995; 74: 214-217.
8. Pohjasvaara T, Leppavuori A, Siira I, Vataja R, Kaste M, Erkinjuntti T. Frequency and clinical determinants of post-stroke depression. Stroke 1998; 29: 2311-2317.
9. Spalletta G, Guida G, De Angelis D, Caltagirone C. Predictors of cognitive level and depression severity are different in patients with left and right hemispheric stroke within the first year of illness. J. Neurol. 2002; 249: 1541-1551.
10. Kimura M, Robinson RG, Kosier T. Treatment of cognitive impairment after poststroke depression: a double-blind treatment trial. Stroke 2000; 31: 1482-1486.
11. Murata Y, Kimura M, Robinson RG. Does cognitive impairment cause poststroke dpression? Am. J. Geriatr. Psychiatry 2000; 8: 310-317.
12. Hamilton M. A rating scale for depression. J. Neurol. Neruosurg. Psychiatry 1960; 23: 56-62.
13. Folenstein MF, Folenstein SE, McHigh PR. 'Mini-Mental State': a practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 1975; 12: 189-198.
14. Andersen G, Vestergaard K, Riis JO, Ingeman-Nielsen M. Dementia of depression or depression of dementia in stroke? Acta Psychiatr. Scand. 1996; 94: 272-278.
15. Robinson RG, Shultz SK, Castillo C et al. Noritriptyline vs Fluoxetine in the treatment of depression and short term recovery following stroke: a placebo controlled double-blind study. Am. J. Psychiatry 2000; 157: 351-359.
16. Wiart L, Petit H, Joseph PA, Mazaux JM, Barat M. Fluoxetine in early poststroke depression. A double-blind placebo controlled study. Stoke 2000; 31: 1829-1832.
17. Ansseau M, Von Frenckell R, Mertens C et al. Controlled comparison of two doses of milnacipran (F2207) and amitriptyline in major depressive inpatients. Psychopharmacology 1989; 98: 163-168.
18. Puech A, Montgomery SA, Prost JF, Solles A, Briley M. Milnacipran, a new serotonin and noradrenaline reuptake inhibitor: an overview of its antidepressant activity and clinical tolerability. Int. Clin. Psyhcopharmacol. 1997; 12: 99-108.
19. Lopez-Ibor J, Guelfi JD, Pletan Y, Tournoux A, Prost JF. Milnacipran and selective serotonin reuptake inhibitors in major depression. Int. Clin. Psychopharmacol. 1996; 11 (Suppl. 4): 41-46.
20. Spencer CM. Milnacipran. A review of its use in depression. Drugs 1998; 56: 405-427.
21. Kimura M, Kanetani K, Imai R, Suzuki H, Isayama K, Endo S. Therapeutic effects of milnacipran, a serotonin and noradrenalin reuptake inhibitor, on post-stroke depression. Int. Clin. Psychopharmacol. 2002; 17: 121-125.
22. Foulkes MA, Wolf PA, Price TR, Mohr JP, Hier DB. The stroke data bank: design, methods, and baseline characteristics. Stroke 1988; 19: 547-554.
23. Sheehan DV, Lecrubier Y, Sheehan K et al. The Mini-International Neuropsychiatric Interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J. Clin. Psychiatry 1998; 59 (Suppl. 20): 22-33.
24. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. American Psychiatric Press Inc, Washington, DC, 1994.
25. Granger C, Hamilton B, Keith R, Zielenzny M, Sherwin F. Advances in functional assessment for medical rehabilitation. Top Geritar. Rehabilil. 1986; 1: 59-74.
26. Hindmarch I, Rigney U, Stanley N, Briley M. Pharmacodynamics of milnacipran in young and elderly volunteers. Br. J. Clin. Pharmacol. 2000; 49: 118-125.
27. Kanetani K, Kimura M, Endo S. Therapeutic effects of milnacipran (serotonin noradrenalin reuptake inhibitor) on depression following mild and moderate traumatic brain injury. J. Nippon Med. Sch. 2003; 70: 313-320.
28. Moller HJ. Are all antidepressants the same? J. Clin. Psychiatry 2000; 61 (Suppl. 6): 24-28.
29. Feher EP, Mahurin RK, Doody RS, Cooke N, Sims J, Pirozzolo FJ. Establishing the limits of the Mini-Mental State Examination of 'subtests'. Arch. Neurol. 1992; 49: 87-92.